# L3MBTL4

## Overview
L3MBTL4 is a gene that encodes the L3MBTL histone methyl-lysine binding protein 4, a chromatin-associated protein involved in the regulation of gene expression through its interaction with methylated lysine residues on histones. This protein plays a significant role in chromatin remodeling and transcriptional repression, influencing cellular processes such as cell cycle regulation and genomic stability (AddouKlouche2010Loss). L3MBTL4 is predominantly localized in the nucleus and is particularly active in vascular smooth muscle cells, where it modulates the MAPK signaling pathway, affecting cellular growth, proliferation, and vascular remodeling (Liu2016Genome). The gene is implicated in various pathological conditions, including breast cancer and hypertension, due to its role in chromatin dynamics and gene regulation (AddouKlouche2010Loss; Liu2016Genome).

## Function
L3MBTL4 is a protein involved in chromatin remodeling and gene regulation, primarily through its ability to bind methylated lysine residues on histones. This binding influences chromatin structure and gene expression, playing a crucial role in cell cycle regulation and maintaining genomic stability (AddouKlouche2010Loss). L3MBTL4 is predominantly localized in the nucleus and is associated with the medial layer of the vasculature, indicating its active role in vascular smooth muscle cells (VSMCs) (Liu2016Genome).

In healthy human cells, L3MBTL4 is implicated in the regulation of the MAPK signaling pathway, which is essential for cellular growth and proliferation. It specifically increases the phosphorylation of p38MAPK and JNK, driving processes such as vascular remodeling (Liu2016Genome). This protein also contributes to the modulation of VSMC phenotype, promoting a switch from a contractile to a synthetic state, which is characterized by changes in the expression of specific markers like osteopontin and SM-22α (Hu2020p38JNK).

L3MBTL4's role in chromatin interaction and transcriptional regulation is suggested by its structural domains, which are involved in transcriptional repression and chromatin remodeling (AddouKlouche2010Loss). These functions are critical for regulating the transcription of various genes, including those involved in stem cell maintenance and oncogenesis.

## Clinical Significance
L3MBTL4 has been implicated in several diseases due to mutations, alterations in expression levels, and disruptions in its normal interactions. In breast cancer, L3MBTL4 is frequently subject to genomic alterations such as loss, mutation, and deregulation. The gene is located on chromosome arm 18p, which shows deletions in approximately 25% of breast tumors. These deletions are associated with high-grade tumors and lymph node metastasis, particularly in the luminal B subtype of breast cancer, which is known for its poor prognosis. L3MBTL4 is considered a candidate tumor suppressor gene due to its frequent deletion, mutation, and downregulation in breast cancers (AddouKlouche2010Loss).

In the context of hypertension, L3MBTL4 has been identified as a novel susceptibility gene. A specific single nucleotide polymorphism (SNP), rs403814, within the L3MBTL4 gene, is significantly associated with hypertension. Overexpression of L3MBTL4 is linked to increased blood pressure and heart hypertrophy, suggesting a pathogenic role in hypertension. The gene's involvement in the MAPK signaling pathway, which contributes to vascular remodeling, further supports its role in the development and progression of hypertension (Liu2016Genome).

## Interactions
L3MBTL4 is involved in interactions that influence vascular remodeling and hypertension through its role in the MAPK signaling pathway. It interacts with the latent transforming growth factor-β binding protein 1 (LTBP1), repressing its expression, which leads to the activation of MAPK signaling pathways, including p38MAPK and JNK. This interaction is crucial for the progression of vascular remodeling associated with hypertension (Liu2016Genome).

In vascular smooth muscle cells (VSMCs), L3MBTL4 overexpression leads to increased cell proliferation and migration, processes that are mediated through the p38 and JNK signaling pathways. Inhibition of these pathways reduces the effects of L3MBTL4, indicating their necessity for L3MBTL4's role in VSMC proliferation and phenotype changes (Hu2020p38JNK).

L3MBTL4 is also associated with chromatin remodeling and gene regulation, as it contains MBT domains that bind methylated histone residues. These interactions suggest a role in transcriptional repression and chromatin structure modulation, although specific protein partners in these processes are not detailed in the provided context (AddouKlouche2010Loss).


## References


[1. (Hu2020p38JNK) Chaowei Hu, Kun Zuo, Kuibao Li, Yuanfeng Gao, Mulei Chen, Roumu Hu, Ye Liu, Hongjie Chi, Hongjiang Wang, Yanwen Qin, Xiaoyan Liu, Jiuchang Zhong, Jun Cai, Xinchun Yang, and Jing Li. P38/jnk is required for the proliferation and phenotype changes of vascular smooth muscle cells induced by l3mbtl4 in essential hypertension. International Journal of Hypertension, 2020:1–12, December 2020. URL: http://dx.doi.org/10.1155/2020/3123968, doi:10.1155/2020/3123968. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1155/2020/3123968)

[2. (AddouKlouche2010Loss) Lynda Addou-Klouche, José Adélaïde, Pascal Finetti, Nathalie Cervera, Anthony Ferrari, Ismahane Bekhouche, Fabrice Sircoulomb, Christos Sotiriou, Patrice Viens, Soraya Moulessehoul, François Bertucci, Daniel Birnbaum, and Max Chaffanet. Loss, mutation and deregulation of l3mbtl4 in breast cancers. Molecular Cancer, August 2010. URL: http://dx.doi.org/10.1186/1476-4598-9-213, doi:10.1186/1476-4598-9-213. This article has 50 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-9-213)

[3. (Liu2016Genome) Xin Liu, Cheng Hu, Minghui Bao, Jing Li, Xiaoyan Liu, Xuerui Tan, Yong Zhou, Yequn Chen, Shouling Wu, Shuohua Chen, Rong Zhang, Feng Jiang, Weiping Jia, Xingyu Wang, Xinchun Yang, and Jun Cai. Genome wide association study identifies l3mbtl4 as a novel susceptibility gene for hypertension. Scientific Reports, August 2016. URL: http://dx.doi.org/10.1038/srep30811, doi:10.1038/srep30811. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep30811)